These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28785052)

  • 21. Impact of clade, geography, and age of the epidemic on HIV-1 neutralization by antibodies.
    Hraber P; Korber BT; Lapedes AS; Bailer RT; Seaman MS; Gao H; Greene KM; McCutchan F; Williamson C; Kim JH; Tovanabutra S; Hahn BH; Swanstrom R; Thomson MM; Gao F; Harris L; Giorgi E; Hengartner N; Bhattacharya T; Mascola JR; Montefiori DC
    J Virol; 2014 Nov; 88(21):12623-43. PubMed ID: 25142591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular clock of HIV-1 envelope genes under early immune selection.
    Park SY; Love TM; Perelson AS; Mack WJ; Lee HY
    Retrovirology; 2016 Jun; 13(1):38. PubMed ID: 27246201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mean Recency Period for Estimation of HIV-1 Incidence with the BED-Capture EIA and Bio-Rad Avidity in Persons Diagnosed in the United States with Subtype B.
    Hanson DL; Song R; Masciotra S; Hernandez A; Dobbs TL; Parekh BS; Owen SM; Green TA
    PLoS One; 2016; 11(4):e0152327. PubMed ID: 27065005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing Biases in the Evaluation of Classification Assays for HIV Infection Recency.
    Patterson-Lomba O; Wu JW; Pagano M
    PLoS One; 2015; 10(10):e0139735. PubMed ID: 26436915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the false recent classification rates of multiassay algorithms in estimating HIV type 1 subtype C incidence.
    Moyo S; LeCuyer T; Wang R; Gaseitsiwe S; Weng J; Musonda R; Bussmann H; Mine M; Engelbrecht S; Makhema J; Marlink R; Baum MK; Novitsky V; Essex M
    AIDS Res Hum Retroviruses; 2014 Jan; 30(1):29-36. PubMed ID: 23937344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection.
    Keele BF; Giorgi EE; Salazar-Gonzalez JF; Decker JM; Pham KT; Salazar MG; Sun C; Grayson T; Wang S; Li H; Wei X; Jiang C; Kirchherr JL; Gao F; Anderson JA; Ping LH; Swanstrom R; Tomaras GD; Blattner WA; Goepfert PA; Kilby JM; Saag MS; Delwart EL; Busch MP; Cohen MS; Montefiori DC; Haynes BF; Gaschen B; Athreya GS; Lee HY; Wood N; Seoighe C; Perelson AS; Bhattacharya T; Korber BT; Hahn BH; Shaw GM
    Proc Natl Acad Sci U S A; 2008 May; 105(21):7552-7. PubMed ID: 18490657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation.
    Cousins MM; Konikoff J; Sabin D; Khaki L; Longosz AF; Laeyendecker O; Celum C; Buchbinder SP; Seage GR; Kirk GD; Moore RD; Mehta SH; Margolick JB; Brown J; Mayer KH; Kobin BA; Wheeler D; Justman JE; Hodder SL; Quinn TC; Brookmeyer R; Eshleman SH
    PLoS One; 2014; 9(6):e101043. PubMed ID: 24968135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody avidity-based approach to estimate population-level incidence of hepatitis C.
    Boon D; Bruce V; Patel EU; Quinn J; Srikrishnan AK; Shanmugam S; Iqbal S; Balakrishnan P; Sievers M; Kirk GD; Thomas DL; Quinn TC; Cox AL; Page KA; Solomon SS; Mehta SH; Laeyendecker O
    J Hepatol; 2020 Aug; 73(2):294-302. PubMed ID: 32240715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC.
    Wood N; Bhattacharya T; Keele BF; Giorgi E; Liu M; Gaschen B; Daniels M; Ferrari G; Haynes BF; McMichael A; Shaw GM; Hahn BH; Korber B; Seoighe C
    PLoS Pathog; 2009 May; 5(5):e1000414. PubMed ID: 19424423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of multi-assay algorithms for identifying individuals with recent HIV infection: HPTN 071 (PopART).
    Grant-McAuley W; Klock E; Laeyendecker O; Piwowar-Manning E; Wilson E; Clarke W; Breaud A; Moore A; Ayles H; Kosloff B; Shanaube K; Bock P; Mandla N; van Deventer A; Fidler S; Donnell D; Hayes R; Eshleman SH;
    PLoS One; 2021; 16(12):e0258644. PubMed ID: 34919554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-1 circulating recombinant form in Nepal.
    Shahid A; Dixit SM; Gurbacharya VL; Karmacharya D; Ali S
    J Virol; 2011 Aug; 85(16):8458. PubMed ID: 21680516
    [No Abstract]   [Full Text] [Related]  

  • 32. Envelope variants circulating as initial neutralization breadth developed in two HIV-infected subjects stimulate multiclade neutralizing antibodies in rabbits.
    Malherbe DC; Pissani F; Sather DN; Guo B; Pandey S; Sutton WF; Stuart AB; Robins H; Park B; Krebs SJ; Schuman JT; Kalams S; Hessell AJ; Haigwood NL
    J Virol; 2014 Nov; 88(22):12949-67. PubMed ID: 25210191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of HIV Recency Assays for HIV Incidence Estimation and Other Surveillance Use Cases: Systematic Review.
    Facente SN; Grebe E; Maher AD; Fox D; Scheer S; Mahy M; Dalal S; Lowrance D; Marsh K
    JMIR Public Health Surveill; 2022 Mar; 8(3):e34410. PubMed ID: 35275085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deep Sequencing of the HIV-1 env Gene Reveals Discrete X4 Lineages and Linkage Disequilibrium between X4 and R5 Viruses in the V1/V2 and V3 Variable Regions.
    Zhou S; Bednar MM; Sturdevant CB; Hauser BM; Swanstrom R
    J Virol; 2016 Aug; 90(16):7142-58. PubMed ID: 27226378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository.
    Kassanjee R; Pilcher CD; Keating SM; Facente SN; McKinney E; Price MA; Martin JN; Little S; Hecht FM; Kallas EG; Welte A; Busch MP; Murphy G;
    AIDS; 2014 Oct; 28(16):2439-49. PubMed ID: 25144218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statistical considerations for cross-sectional HIV incidence estimation based on recency test.
    Gao F; Bannick M
    Stat Med; 2022 Apr; 41(8):1446-1461. PubMed ID: 34984710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of HIV-1 genotype specific antigens for the detection of recent and long-term HIV-1 infection in China.
    Cai Q; Wang H; Huang L; Yan H; Zhu W; Tang S
    Virus Res; 2019 Apr; 264():16-21. PubMed ID: 30794896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance evaluation of the Asante Rapid Recency Assay for verification of HIV diagnosis and detection of recent HIV-1 infections: Implications for epidemic control.
    Yufenyuy EL; Detorio M; Dobbs T; Patel HK; Jackson K; Vedapuri S; Parekh BS
    PLOS Glob Public Health; 2022; 2(5):e0000316. PubMed ID: 36962217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of HIV-1 CRF01_AE
    Sasaki M; Kotaki T; Khairunisa SQ; Tachibana S; Ophinni Y; Hayashi Y; Nasronudin ; Kameoka M
    AIDS Res Hum Retroviruses; 2020 Mar; 36(3):242-247. PubMed ID: 31580700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surveillance of HIV type 1 recent infection and molecular epidemiology among different risk behaviors between 2007 and 2009 after the HIV type 1 CRF07_BC outbreak in Taiwan.
    Kao CF; Chang SY; Hsia KT; Chang FY; Yang CH; Liu HR; Fu TY; Yang JY
    AIDS Res Hum Retroviruses; 2011 Jul; 27(7):745-9. PubMed ID: 21235402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.